These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30558894)

  • 1. Causal Role of Bile Acids in Irritable Bowel Syndrome-Constipation.
    Hofmann AF
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):213-214. PubMed ID: 30558894
    [No Abstract]   [Full Text] [Related]  

  • 2. Bile Acids and Bowel Function: Do They Play a Role in Constipation-Associated Irritable Bowel Syndrome?
    Wald A
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):486-487. PubMed ID: 29155167
    [No Abstract]   [Full Text] [Related]  

  • 3. Bile acids and dioctyl sodium sulfosuccinate in constipation and irritable colon.
    KING JC
    Am J Gastroenterol; 1961 Jan; 35():50-60. PubMed ID: 13756083
    [No Abstract]   [Full Text] [Related]  

  • 4. Bile Acid Deficiency and Constipation.
    Palmer RH
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1363-1364. PubMed ID: 30033178
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply.
    Camilleri M
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):214. PubMed ID: 30558895
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply.
    Vijayvargiya P; Camilleri M
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1364. PubMed ID: 30033179
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation.
    Abrahamsson H; Ostlund-Lindqvist AM; Nilsson R; Simrén M; Gillberg PG
    Scand J Gastroenterol; 2008; 43(12):1483-8. PubMed ID: 18788050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging pharmacological therapies for the irritable bowel syndrome.
    Maneerattanaporn M; Chang L; Chey WD
    Gastroenterol Clin North Am; 2011 Mar; 40(1):223-43. PubMed ID: 21333909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for bile acid diarrhoea in suspected irritable bowel syndrome.
    Aziz I; Kurien M; Sanders DS; Ford AC
    Gut; 2015 May; 64(5):851. PubMed ID: 24870624
    [No Abstract]   [Full Text] [Related]  

  • 10. Combining biomarkers in irritable bowel syndrome: a forward step toward making a positive diagnosis and directing therapy?
    Sood R; Ford AC
    Gastroenterology; 2015 Jun; 148(7):1471-3. PubMed ID: 25921375
    [No Abstract]   [Full Text] [Related]  

  • 11. Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?
    Camilleri M; Halawi H; Oduyebo I
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):303-316. PubMed ID: 28128666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
    Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM
    Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Authors' response: bile acids are important in the pathophysiology of IBS.
    Bajor A; Törnblom H; Rudling M; Ung KA; Simrén M
    Gut; 2015 May; 64(5):851-2. PubMed ID: 25056657
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome.
    Camilleri M; Acosta A; Busciglio I; Boldingh A; Dyer RB; Zinsmeister AR; Lueke A; Gray A; Donato LJ
    Aliment Pharmacol Ther; 2015 Mar; 41(5):438-48. PubMed ID: 25594801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of bile acids in the pathogenesis of chronic diarrhea].
    Krums LM; Gubina AV; Parfenov AI; Sil'vestrova SIu
    Eksp Klin Gastroenterol; 2012; (3):35-9. PubMed ID: 22830222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is the colon oversalted in irritable bowel syndrome?].
    Gebbensleben OH
    Z Gastroenterol; 2014 Feb; 52(2):224-5. PubMed ID: 24526408
    [No Abstract]   [Full Text] [Related]  

  • 17. Patients with irritable bowel syndrome or constipation have an increased risk for ischaemic colitis.
    Suh DC; Kahler KH; Choi IS; Shin H; Kralstein J; Shetzline M
    Aliment Pharmacol Ther; 2007 Mar; 25(6):681-92. PubMed ID: 17311601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of the reported prevalence of bile salt malabsorption in irritable bowel.
    Ford AC
    Aliment Pharmacol Ther; 2010 Jan; 31(1):161-2; author reply 162-4. PubMed ID: 20002031
    [No Abstract]   [Full Text] [Related]  

  • 19. Abnormal colonic propagated activity in patients with slow transit constipation and constipation-predominant irritable bowel syndrome.
    Bassotti G; Chistolini F; Marinozzi G; Morelli A
    Digestion; 2003; 68(4):178-83. PubMed ID: 14671425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.
    Johanson JF; Drossman DA; Panas R; Wahle A; Ueno R
    Aliment Pharmacol Ther; 2008 Apr; 27(8):685-96. PubMed ID: 18248656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.